PT Kalbe Farma Tbk (KLBF) is optimistic about the prospects for the pharmaceutical business throughout 2022. Thus, Kalbe Farma still maintains its net sales growth target of 11% for 2022. In 2021, KLBF's net sales were recorded at Rp 26.26 trillion. This means that KLBF is projected to obtain net sales of around Rp 29.15 trillion this year. Meanwhile, in the first semester of 2022, KLBF's net sales grew 12.2% year on year (YoY) to Rp 13.87 trillion.
September 20 2022, Kontan